131 related articles for article (PubMed ID: 25726719)
1. Action of anti-M₃muscarinic acetylcholine receptor IgG of primary Sjögren's syndrome on the enzymatic antioxidant system in rat submandibular gland.
Reina S; Rodríguez M; Stranieri G; Borda E
J Oral Pathol Med; 2015 Nov; 44(10):876-83. PubMed ID: 25726719
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP.
Passafaro D; Reina S; Sterin-Borda L; Borda E
Eur J Oral Sci; 2010 Apr; 118(2):131-8. PubMed ID: 20487001
[TBL] [Abstract][Full Text] [Related]
3. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
[TBL] [Abstract][Full Text] [Related]
4. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors.
Bacman SR; Berra A; Sterin-Borda L; Borda ES
Curr Eye Res; 1998 Dec; 17(12):1135-42. PubMed ID: 9872535
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sjögren's syndrome.
Reina S; Passafaro D; Sterin-Borda L; Borda E
Inflammopharmacology; 2012 Oct; 20(5):267-75. PubMed ID: 22441579
[TBL] [Abstract][Full Text] [Related]
6. Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis.
Orman B; Sterin-Borda L; De Couto Pita A; Reina S; Borda E
Int Immunopharmacol; 2007 Dec; 7(12):1535-43. PubMed ID: 17920530
[TBL] [Abstract][Full Text] [Related]
7. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren syndrome antibodies.
Pérez Leirós C; Sterin-Borda L; Hubscher O; Arana R; Borda ES
Clin Immunol; 1999 Feb; 90(2):190-5. PubMed ID: 10080830
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
Bacman S; Berra A; Sterin-Borda L; Borda E
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):321-7. PubMed ID: 11157861
[TBL] [Abstract][Full Text] [Related]
9. Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands.
Reina S; Sterin-Borda L; Passafaro D; Borda E
Arch Oral Biol; 2011 May; 56(5):413-20. PubMed ID: 21371688
[TBL] [Abstract][Full Text] [Related]
10. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
Kim N; Shin Y; Choi S; Namkoong E; Kim M; Lee J; Song Y; Park K
J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
[TBL] [Abstract][Full Text] [Related]
12. Anti-M(3) peptide IgG from Sjögren's syndrome triggers apoptosis in A253 cells.
Reina S; Sterin-Borda L; Borda E
Cell Immunol; 2012; 275(1-2):33-41. PubMed ID: 22513175
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome.
Bacman S; Perez Leiros C; Sterin-Borda L; Hubscher O; Arana R; Borda E
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):151-6. PubMed ID: 9430556
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.
Li J; Ha YM; Kü NY; Choi SY; Lee SJ; Oh SB; Kim JS; Lee JH; Lee EB; Song YW; Park K
Lab Invest; 2004 Nov; 84(11):1430-8. PubMed ID: 15448705
[TBL] [Abstract][Full Text] [Related]
16. Cholinoreceptor autoantibodies in Sjögren syndrome.
Reina S; Orman B; Anaya JM; Sterin-Borda L; Borda E
J Dent Res; 2007 Sep; 86(9):832-6. PubMed ID: 17720850
[TBL] [Abstract][Full Text] [Related]
17. [The clinical significance of autoantibodies against acetylcholine muscarinic 3 receptor in primary Sjögren's syndrome].
Wu Y; Li MT; Zhao Y; Feng S; Su L; Dong Y
Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):563-5. PubMed ID: 19035167
[TBL] [Abstract][Full Text] [Related]
18. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
[TBL] [Abstract][Full Text] [Related]
19. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
[TBL] [Abstract][Full Text] [Related]
20. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
